News for 'Indian Institute of Chemical Biology'

Breakthrough In Textile Wastewater Treatment By IIT And BHU Researchers

Breakthrough In Textile Wastewater Treatment By IIT And BHU Researchers

Rediff.com16 Sep 2026

Researchers from IIT Guwahati and BHU have devised an eco-friendly biological method to treat textile wastewater, specifically targeting toxic azo dyes. Their novel bacterium, 'Brevundimonas sp. AJZ05', effectively degrades 98.50 per cent of Direct Blue-6 dye, producing non-toxic byproducts, offering a sustainable alternative to conventional chemical treatments.

Nature-Based System From IIT Guwahati Tackles Piggery Pollution

Nature-Based System From IIT Guwahati Tackles Piggery Pollution

Rediff.com5 Oct 2026

Researchers at the Indian Institute of Technology (IIT), Guwahati, have developed an innovative nature-based wastewater treatment system utilising taro plants and an engineered "zig-zag flow" design. This low-energy, compact technology offers a promising solution for treating highly polluted swine wastewater in decentralised livestock farms, particularly in rural and resource-limited regions.

Breakthrough Nanopore Technology Detects Neurodegenerative Disease Biomarkers Early

Breakthrough Nanopore Technology Detects Neurodegenerative Disease Biomarkers Early

Rediff.com28 Aug 2026

Researchers at BRIC-RGCB in Thiruvananthapuram have developed a novel nanopore-based sensing technology. This innovation allows for the early and highly sensitive detection of biomarkers associated with neurodegenerative diseases like Parkinson's and ALS, addressing a critical challenge in current diagnostic methods. The technology, published in Nature Nanotechnology, uses self-assembling dual-diameter nanopore sensors to identify disease-specific biomarkers even at low concentrations.

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

Rediff.com20 Aug 2026

Researchers at Delhi's Indraprastha Institute of Information Technology have developed 'MutAIverse', a generative AI platform designed to decode DNA damage and identify potential causes of cancer. Tested on head and neck cancer patients in Guwahati, the platform successfully traced exposure to smokeless tobacco as a contributing factor. This innovation aims to shift focus from just diagnosis to understanding causative factors, potentially aiding in prevention and protection.

Why India Needs A Unique AI Safety Framework

Why India Needs A Unique AI Safety Framework

Rediff.com4 Oct 2026

Industry experts advocate for India to develop its own artificial intelligence (AI) safety framework, distinct from US or EU models, to address unique challenges like deepfakes and cyberattacks. They call for a comprehensive commitment involving all stakeholders and a hybrid regulatory approach combining voluntary and binding measures, as the Indian government also considers new AI regulations.

For Rs 2, E-Eye Can Check If Water Is Safe

For Rs 2, E-Eye Can Check If Water Is Safe

Rediff.com18 Aug 2026

E-Eye, which cost about Rs 3,500 to develop, can test a sample for around Rs 2, making it particularly suitable for field-level water quality monitoring in areas where access to sophisticated laboratories is limited.

IIT-Guwahati To Commercialise Bio-Methanol Production

IIT-Guwahati To Commercialise Bio-Methanol Production

Rediff.com28 May 2026

IIT-Guwahati has partnered with Kaashyap Cleantech Innovations to commercialise bio-methanol production technology, which converts greenhouse gases into a versatile liquid fuel, offering environmental and performance benefits.

India-Sweden Project Uses AI to Fight Pneumonia

India-Sweden Project Uses AI to Fight Pneumonia

Rediff.com31 Mar 2026

A new research collaboration between India and Sweden is using artificial intelligence to accelerate the discovery of peptide-based therapeutics for pneumonia, aiming to shorten drug development timelines and combat drug-resistant infections.

IIT Bombay Develops DNA Strategy to Combat Antibiotic Resistance

IIT Bombay Develops DNA Strategy to Combat Antibiotic Resistance

Rediff.com26 Mar 2026

Researchers at IIT Bombay have developed a DNA-based strategy to make drug-resistant bacteria responsive to antibiotics again, addressing the growing crisis of antimicrobial resistance.

Graphene Sensors Poised to Transform Medical Testing

Graphene Sensors Poised to Transform Medical Testing

Rediff.com12 Mar 2026

Scientists at the GraphIN 2026 conference highlighted the potential of ultra-sensitive graphene sensors for rapid disease detection and various other applications, including flexible heating pads for neonatal care and lightweight structures for unmanned aerial vehicles.

Indian scientists claim cure for diabetes

Indian scientists claim cure for diabetes

Rediff.com7 Jan 2004

Dr S Bhattacharya of Indian Institute of Chemical Biology, Kolkata, said the drug has been developed from a plant found in West Bengal's Purulia Hills.

IISER Aptitude Test Applications To Open On March 10

IISER Aptitude Test Applications To Open On March 10

Rediff.com8 Mar 2025

The IISER Aptitude Test is conducted for students who wish to get admission to IISER.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

'We Aren't Security Conscious As A Nation'

'We Aren't Security Conscious As A Nation'

Rediff.com6 Nov 2025

'Government officials use Gmail and ordinary phones without basic security consciousness.' 'Interoperability, especially in joint exercises with countries like the US, worries me.' 'It often means we open our systems to them, but they don't reciprocate.' 'They could have kill switches in their systems and might even be able to affect ours.'

Dropping Darwinian evolution may lead to superstitious beliefs, warn experts

Dropping Darwinian evolution may lead to superstitious beliefs, warn experts

Rediff.com9 May 2023

The Theory of Evolution, proposed by the English naturalist, explains that all living beings evolved through natural selection, which favours inherited traits that improve an individual's ability to compete, survive, and reproduce.

Top 10 universities in the world

Top 10 universities in the world

Rediff.com6 Mar 2018

The QS World Rankings lists the best educational institutes in the world.

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

Alert: PhD, Masters at IIT Kanpur

Alert: PhD, Masters at IIT Kanpur

Rediff.com18 Mar 2004

Information you can use.

Campus Placements At IITs Getting Tough

Campus Placements At IITs Getting Tough

Rediff.com8 Jul 2024

Nearly 40 per cent of IITians sitting for placements in 2024 are yet to receive job offers, showing a doubling of the 'unplaced' in the last three years from 19 per cent in 2021-2022 to 38 per cent in 2023-2024.

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

Rediff.com14 Apr 2021

The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.

5 SUPER COOL courses you should pursue in 2020

5 SUPER COOL courses you should pursue in 2020

Rediff.com19 Dec 2019

Did you know that ethical hackers earn anything between Rs 800 to Rs 1,000 per hour?

New Covid lineage identified, 2nd in India after 'double mutant' virus

New Covid lineage identified, 2nd in India after 'double mutant' virus

Rediff.com22 Apr 2021

The new lineage called B.1.618 is distinct from the B.1.617, also known as the 'double mutant' virus that contains two mutations, E484Q and L245R, and is believed to be behind the powerful second COVID-19 wave sweeping through India.

'Malaysia strain' COVID-19 virus no cause for concern

'Malaysia strain' COVID-19 virus no cause for concern

Rediff.com20 Aug 2020

While some reports claim the mutation is capable of enhancing the infectivity of the virus, this is not well established and also does not necessarily indicate more virulence or harmfulness of the disease.

6 professors awarded Infosys Prize 2019 for science and research

6 professors awarded Infosys Prize 2019 for science and research

Rediff.com7 Nov 2019

The annual award includes a pure gold medal, a citation and a prize purse worth $ 100,000 or its equivalent in the Indian rupees.

Oxford COVID-19 vaccine promising, but...: Scientists

Oxford COVID-19 vaccine promising, but...: Scientists

Rediff.com21 Jul 2020

Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.

2021: How Covid kept the world on tenterhooks, with surprises aplenty

2021: How Covid kept the world on tenterhooks, with surprises aplenty

Rediff.com29 Dec 2021

As the Omicron strain spreads across the globe and questions on vaccine inequity dominate discussions, scientists are still scrambling to learn more about emerging variants of the deadly virus that has claimed millions of lives and crippled economies.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

'Most countries won't forgive deaths of children'

'Most countries won't forgive deaths of children'

Rediff.com22 Nov 2022

'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'

'Plan to nuke Surat sounds fantastical'

'Plan to nuke Surat sounds fantastical'

Rediff.com9 May 2023

'You are dealing with a small gang of semi-literate terrorists. These are guys flying kites.' 'There is huge difference between flying kites and actually having a deliverable, executable, plan.'

These Scientists Shaped India

These Scientists Shaped India

Rediff.com15 Aug 2023

I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.

Giant In The Earth: M S Swaminathan

Giant In The Earth: M S Swaminathan

Rediff.com5 Oct 2023

Dr Shreekant Sambrani pays tribute to M S Swaminathan, renowned agricultural scientist and a lifelong crusader against hunger who passed away in Chennai recently.

Omicron variant stokes concern but vaccine still critical: Experts

Omicron variant stokes concern but vaccine still critical: Experts

Rediff.com29 Nov 2021

The Omicron variant carries 'concerning' mutations that may make it more transmissible and allow it to evade immunity, scientists said on Monday, stressing that the one certainty in the uncertainty of the many things unknown is this -- COVID is not a short-term crisis and vaccines are still a critical tool.

More children infected with Covid in 2nd wave: Experts

More children infected with Covid in 2nd wave: Experts

Rediff.com25 May 2021

Though there is enough anecdotal evidence of COVID-19 catching children -- early teens and younger -- there is little reason to panic, said several doctors and scientists. They also stressed on the urgent need to vaccinate children to stem the spread of the infection.

Bharat Biotech to make 900 million Covaxin vaccines

Bharat Biotech to make 900 million Covaxin vaccines

Rediff.com1 Jun 2021

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.

US approves sale of 6 Apache attack choppers to India

US approves sale of 6 Apache attack choppers to India

Rediff.com13 Jun 2018

In addition to the attack helicopters, the contract also includes fire control radars; Hellfire Longbow missiles; stinger Block I-92H missiles; night vision sensors and inertial navigation systems.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

GMOs - from war to dialog?

GMOs - from war to dialog?

Rediff.com28 Nov 2013

Indian scientists who wrote to the PM last week are not entirely rejecting GMOs but instead asking for caution and further testing to establish their safety.

How tech alumni plan to raise 21,000 crore to fight COVID-19

How tech alumni plan to raise 21,000 crore to fight COVID-19

Rediff.com2 Jul 2020

Over 5 million alumni from the Indian Institutes of Technology, Mumbai University and Institute of Chemical Technology, Mumbai, plan to raise Rs 21,000 crore to start the world's largest infection testing lab in Mumbai.